Jamie E Ziggas
Overview
Explore the profile of Jamie E Ziggas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Norman H, Ziggas J, Bolanos-Meade J, Porter T
Transplant Cell Ther
. 2025 Mar;
PMID: 40043847
Post-transplantation cyclophosphamide (PTCy) is standard graft-versus-host disease (GVHD) prophylaxis for allogeneic blood or marrow transplantation (alloBMT), although optimal therapeutic levels of immunosuppression (IS) therapy combined with PTCy remain contested. Previously,...
2.
Skoloda D, Newman M, Norman H, Ziggas J, Ambinder R
JCO Oncol Pract
. 2024 Feb;
20(5):673-677.
PMID: 38382007
Purpose: High-dose methotrexate (HDMTX) is an antineoplastic dosing strategy used to treat various cancers including primary central nervous system lymphoma. Trimethoprim-sulfamethoxazole (TMP/SMX) is commonly used for antibiotic prophylaxis against pneumonia...
3.
Porter T, Lazarevic A, Ziggas J, Fuchs E, Kim K, Byrnes H, et al.
Br J Haematol
. 2022 Sep;
199(5):720-727.
PMID: 36111395
Haemophagocytic lymphohistiocytosis-like toxicity following chimeric antigen receptor T cells (CAR-HLH) is being increasingly recognized, while published data are limited and criteria for recognition are elusive. We describe three patients who...